Venipuncture and Pre-/Analytical/Analytical/Post-Analytical Error Notes (Page-by-Page)

Page 1 — Venipuncture Equipment, Errors and Capillary Collection

• Visual/content focus: Venipuncture equipment, common errors, and capillary collection methods. Likely introduction to the tools used for blood collection (e.g., Microtainer tubes, band tubes, brand examples such as MICRO… and related items).
• Theme: Setting up the session on how collection happens, what equipment is used, and how errors can occur in the pre-analytical phase.

Page 2 — Types, Variations, Use, Identify, Correct, and the 5 “W”s; Venipuncture Equipment, Anticoagulants; Pre/Analytical/Post-Analytical Errors; Today’s Agenda; Additives; Activators; Order of Draw

• Major ideas:
  • Types and variations of collection devices and additives; use-cases for each type.
  • How to identify and correct issues in the venipuncture process.
  • The “5 W’s” (Who, What, When, Where, Why) to frame pre-analytical planning.
  • Overview of equipment, anticoagulants, and the scope of pre-, analytical, and post-analytical errors.
  • Agenda items for today: Additives, activators, order of draw, and how these influence results.

Page 3 — Pre-Analytical, Analytical, Post-Analytical Errors

• Three major phases of the laboratory workflow:
  • Pre-Analytical: from test ordering to just before analysis. This is the stage with the most errors.
  • Analytical: the actual testing/measurement phase.
  • Post-Analytical: reporting, interpretation, and communication of results.
• Emphasis: The slide layout distinguishes these three phases as the framework for discussing errors.

Page 4 — Laboratory Error Definition

• Definition: A defect occurring at any part of the laboratory cycle, from ordering tests, reporting, interpreting reactions to results.
• Implication: Errors can arise at any stage; identifying and mitigating them requires attention across the entire cycle.

Page 5 — Analytical Errors; Phases

• Clarification: Analytical errors encompass issues during testing but are linked to the three phases (Pre-Analytical, Analytical, Post-Analytical).
• Note: A line item indicates “F” which appears extraneous; core idea remains the connection between analytical errors and phase interactions.

Page 6 — Scope of Pre-Analytical Phase

• Includes all steps from ordering the test up to right before analysis.
• Key statistic: Approximately 90% of errors occur in the pre-analytical phase.
• Emphasis: Strengthening pre-analytical processes yields the largest impact on overall accuracy.

Page 7 — Pre-Analytical Errors: Step 1–5

Pre-Analytical error sources can arise from:

• 1) Test Ordering
• 2) Patient Identification
• 3) Patient Preparation
• 4) Site Selection + Preparation
• 5) Tourniquet Application + Time
• This page lists the key decision points where errors can be introduced before collection.

Page 8 — Pre-Analytical Errors: Step 6–12

Continuing the list of pre-analytical steps prone to error:

• 6) Venipuncture Technique
• 7) Appropriate Samples/Tubes Collected
• 8) Order of Draw
• 9) Correct Volume
• 10) Centrifugation
• 11) Proper Handling
• 12) (implied) Additional handling steps or quality checks
• Takeaway: The quality of each step influences the integrity of the specimen and the accuracy of downstream results.

Page 9 — Test Ordering Details

• Requisitions should contain: minimum patient name, age, health card number, phone number.
• Hospital information: brief clinical details.
• Clinic information: not always provided.
• Common errors in ordering: confusion with similar patient names, transcription errors, misinterpreted verbal orders, or missed orders entirely.

Page 10 — Patient Identification Risks

• Patient ID risks include being a major and highly dangerous source of pre-analytical error.
• Traditional identifiers include hospital ID bracelets (now with barcodes).
• Consequences of misidentification: fatal hemolytic transfusion reactions, treatment of wrong conditions, unnecessary additional tests, and broader patient risk.
• Positive vocal identification by patient can help mitigate risk; staff or family members may assist if patient cannot provide ID.

Page 11 — Best Practices for Labeling and Identification

• Do not label tubes prior to venipuncture.
• Double-check that requisition information matches the labels.
• Use positive vocal identification when feasible.
• Label tubes while the patient is in front of you, and do not complete labeling until identification is verified.

Page 12 — Patient Preparation

• Patients should be informed and asked for consent to draw blood.
• Collect pertinent information at the time of preparation.
• Key question example: When was the patient last fed or drank anything? (relevant for certain tests)

Page 13 — Site Selection

• Consider whether the patient has an IV running, as this can affect results.
• Choose sites free from conditions that could bias results: mastectomy history, burns, scratches, rashes, bruises.
• Go-to vein sites: median cubital and cephalic veins.
• Rationale: proper site selection reduces hemolysis and improves sample quality.

Page 14 — Tourniquet Application

• Tourniquet should be applied for up to 1 minute; after collection, remove or switch to the other arm.
• Prolonged tourniquet use causes hemoconcentration, falsely elevating analytes such as glucose, potassium, and protein.
• Key cautions: minimize dwell time to preserve specimen integrity.

Page 15 — Venipuncture Technique

• Permit up to 2 attempts; after the second failed attempt, another clinician should attempt (e.g., MLA/phlebotomist/nurse).
• Alcohol must be applied and allowed to dry fully before puncture.
• Use appropriately sized needles; improper needle placement is a risk.

Page 16 — Specimen Handling and Tubes (Handling Tips)

• Do not vigorously shake collected specimens.
• Do not transfer contents between tubes; use a single container/tile per tube.
• Insufficient mixing can cause microclots; specimens should be centrifuged within one hour of collection.
• A note about clotted samples: tubes must be fully clotted before centrifugation; incomplete clotting leads to erroneous results.

Page 17 — Order of Draw (General Principle)

• Purpose: prevent contamination of samples by additives from previous tubes.
• Additives can interfere with clotting factors; hence, sodium citrate (light blue) is drawn first with an anticoagulant.
• EDTA is high in potassium and can interfere with chemistry results if drawn too early.
• In short: Follow the specified order of draw to minimize carryover and bias in results.

Page 18 — Volume and Fill Levels

• Maintain the appropriate blood-to-additive ratio for each tube.
• Allow tubes to fill until the flow stops; avoid under- or over-filling.
• Special note: butterfly needles require care when collecting sodium citrate or pediatric samples.
• Under-filling can alter the concentration of additives; over-filling can dilute the additive and compromise results.
• Practical implication: adhere to manufacturer guidance for each tube type.

Page 19 — Centrifugation Parameters

• Insufficient centrifugation time or speed can alter test results.
• Centrifugation must be performed properly; balance the centrifuge with all samples.
• Note: CBCs are not to be spun (as a general guideline given in this slide context).

Page 20–21 — Common Pre-Analytical Errors (List)

• 1. Missing sample / test request
• 2. Wrong ID on the sample
• 3. No label
• 4. Leaking sample
• 5. Hemolyzed / Clotted
• 6. Inappropriate container
• 7. Inappropriate ratio of sample to anticoagulant
• 8. Additional pre-analytical errors (as listed; the slides group and enumerate common errors)

Page 22–23 — Labeling Details

• Always label the tube directly.
• Considerations: printed labels versus hand sanitizer contamination risks; ensure label is applied straight, smooth, and at an appropriate height.
• Do not label multiple items with a single label.
• Labeling standards: unique identifiers must be visible; barcode alignment for scanners; leave a visible window so lab personnel can verify the sample.

Page 24 — Decorative/Non-Technical Slide

• A slide titled “Worst Dressed” with a name (Paul Lim) appears to be a decorative or humor slide and not a core technical point.

Page 25–27 — Analytical Errors and Prevention

• Analytical errors occur during the testing itself and include equipment malfunction, sample mix-ups, and interferences.
• Scenarios of analytical errors include out-of-range control results, incorrectly prepared reagents, improper reagent storage, and maintenance lapses (sensor, dilution, pipetting).
• Prevention strategies:
  • Regular equipment maintenance and calibration
  • Adherence to standard operating procedures (SOPs)
  • Regular competency assessments for staff
  • Clear communication
  • Avoid lot-to-lot mix-ups
  • Careful checking of dates and reagents

Page 28 — Warnings on Automation

• Automation-related warnings include: probe block, temperature error, voltage change, bubble, clot, short sample.
• Implication: Automated systems require monitoring and validation to prevent erroneous results.

Page 29–33 — Post-Analytical Errors and Communication

• Post-Analytical stage focuses on reporting and communication of results.
• Common post-analytical errors include clerical errors and verbal miscommunication.
• Follow-up and verification practices:
  • Most common post-analytical error is improper verification of results; ensure double-checks.
  • Clerical errors in high-automation environments: bidirectional interfaces can double-feed data; implement dual checks for manually entered results; avoid multitasking during data entry.
  • Verbal miscommunication: ensure patients and staff receive reports; use auto-fax, auto-email, or hard copies when appropriate.
  • Read-back policy: maintain a strict read-back protocol for critical results.
• Additional measures: ensuring reports reach patients and clinicians timely; documenting downtime, turn-around time (TAT), and report disposition.

Page 34–35 — Questions and Focus on Venipuncture Equipment

• Q&A frame to address uncertainties.
• Recap: Core focus on venipuncture equipment and the procedural steps in blood collection.

Page 36–39 — Venipuncture Equipment and Collection Stations

• Essential equipment in blood collection carts/trays:
  • Tourniquet
  • Sterile disposable needle
  • Needle holder/barrel
  • Vacutainer tubes / Microtainers
  • Special equipment for blood cultures
  • Alcohol
  • Cotton balls
  • Tape or Band-aids
  • Gloves
  • Sharps container
  • Syringes or winged infusion set
  • Labels / Requisition forms
• Patients: Inpatients (hospital) vs. Outpatients (collection stations, phlebotomy chairs, or stretchers).
• Collection facilities: Hospital settings, outpatient clinics, community collection facilities.

Page 38–41 — Collection Stations and Equipment Configurations

• Blood Drawing Stations: include stocked supplies and patient seating; can have stretchers for fainting risk.
• Phlebotomy Chairs: designed for blood draws with adjustable components (armrests, swingable arm, height adjustment).
• Portable/Grab-and-Go Options: handheld trays for STAT or emergency draws; useful when access via elevator/power is limited or in emergencies.

Page 42–43 — Phlebotomy Carts and Gloves

• Phlebotomy carts: multiple shelves; used for high-volume morning collections (20–30+ patients); can be away from labs for short periods; purpose is to prevent nosocomial infection by keeping supplies out of patient rooms.
• Gloves: mandatory for all draws; change gloves between patients; size matters for palpation and comfort; ill-fitting gloves hinder venipuncture.

Page 44–46 — Tourniquets, Alcohol, and Needles

• Tourniquets: primary method to locate a vein; available in latex and non-latex; one-time use or cleaned per policy.
• Alcohol: typically 70% isopropyl; applied in a back-and-forth motion; should remain on skin for 30–60 seconds before puncture; patients with allergies may require iodine or chlorhexidine; ensure the area dries to avoid stinging during puncture.
• Needles: gauge indicates diameter; larger gauge means smaller needle; sterile, disposable, one-time use; needle parts include point, bevel, and shaft; needle length varies.
• Hub, Shaft, Lumen, Bevel: key parts identified for needle anatomy.

Page 47–49 — Needle Anatomy and Gauge Coding

• Bevel, Shaft, Threaded hub, Rubber sleeve over needle, Multisample needle, Tube holder, Evacuated tube details.
• Needle gauge guidance (rule of thumb):
  • Adults: 20–21 gauge
  • Children: 22–23 gauge
  • Infants/Babies: 23–25 gauge
• Color coding by gauge size (typical scheme): Black = 22, Green = 21 (note: color codes can vary by manufacturer).
• Multi-sample needles: A/B configurations for different tubes; 2002/98271 seems to be slide-id data rather than technical content.

Page 50–51 — Needles and Syringes in Practice

• Needles for phlebotomy: double-ended with one tip in the patient and a second tip piercing the tube stopper; retractable rubber sleeve covers the second tip when not in use.
• Syringes: used when vacuum from vacutainer tubes could collapse fragile veins or in non-cooperative patients; consist of a plunger, barrel, and needle; blood may be seen as a flash when in the vein.

Page 52–53 — Syringe Collection and Handling

• Blood must be transferred to evacuated tubes immediately to prevent clotting; when using syringes, avoid forcing blood into tubes and do not open caps to facilitate filling.
• Immediate transfer ensures specimens are collected under controlled conditions and reduces clotting risk.

Page 54–57 — Butterfly Needles, Holders, and Evacuated Tubes

• Butterfly needles (winged infusion set): used for patients with fragile or small veins (children and the elderly) and when venous access is challenging; minimizes strong vacuum to prevent vein collapse; commonly used for blood culture bottle collections.
• Holders/Barrels: plastic, disposable components with threaded hubs for needles and large openings for tubes; adapters exist for pediatric collections.
• Evacuated Tubes (Vacutainer system): tubes with color-coded tops containing various additives; vacuum inside draws a measured volume of blood; grey, purple, pink, blue, red, etc., correspond to different additives.

Page 57–60 — Evacuated Tubes, Vacuum, and Stoppers

• Tubes are vacuum-sealed at manufacture with a pre-measured blood volume; the vacuum drives the fill volume automatically.
• Storage and expiration problems can cause vacuum loss, tube opening, or expired tubes leading to improper fill.
• Stoppers: rubber, pierceable by needles; color-coded to indicate the anticoagulant or special properties; some tubes have multiple color codes to indicate dual additives.

Page 61–63 — Order of Draw and Inversion

• Order of Draw: must be followed to prevent carryover of additives from previous tubes; the same order applies to syringe collections; carryover can alter tests.
• EDTA has strong potential to contaminate subsequent tubes; this drives the rationale for a strict sequence.
• Each anticoagulant has a designated amount per tube and tubes should be inverted gently (not vigorously) to mix thoroughly.
• Inversion count varies by additive; typical guidance is to invert as per manufacturer instructions to ensure proper mixing without foaming or sample loss.

Page 64–68 — Anticoagulants Overview

• Anticoagulants are additives that prevent clotting and enable specific tests by preserving plasma or whole blood.
• Types include EDTA, citrate, heparin, oxalates, SPS, and fluoride-containing additives; each is selected based on the test ordered.
• EDTA (ethylenediaminetetraacetic acid) exists in two formulations:
  • K2EDTA (dipotassium)
  • K3EDTA (tripotassium)
• EDTA is commonly used for hematology testing and blood banks to preserve cell morphology; excessive EDTA can cause red blood cell shrinkage.
• EDTA is present in purple/lavender top tubes, pink top tubes, and small amounts in royal blue tops.
• Citrates (primarily sodium citrate) prevent coagulation by binding calcium and are used for coagulation testing (PT, aPTT, D-dimer, etc.); light blue stoppers require immediate gentle inversions (3–4x) and must be filled in a 9:1 blood-to-additive ratio.
• Heparin (ammonium, lithium, sodium) comes in various forms; lithium and sodium heparin are most common; lithium used for certain lithium level testing. Heparin prevents clotting by inhibiting thrombin and is frequently used in chemistry panels.
• Some heparin tubes include a gel separator (PST: Plasma Separator Tube) that creates a barrier between plasma and cells after centrifugation.
• Oxalates (potassium oxalate) are anticoagulants used with fluoride in gray-stopper tubes for glucose testing; they prevent coagulation by binding calcium and require 8–10 inversions.
• SPS (sodium polyanethol sulfonate) is used for blood cultures; a yellow/bana­na yellow stopper indicates this additive; must invert immediately (8–10x).
• Sodium fluoride is an antiglycolytic agent used to preserve glucose; typically in gray-stopper tubes; immediately invert with 5–10x.

Page 69–71 — Proper Name and Use of EDTA; Citrates; and RBC Morphology

• EDTA’s blood preservation role is to prevent calcium-dependent coagulation and preserve cellular morphology; excess EDTA can shrink RBCs.
• EDTA presence in common tubes (purple/lavender, pink, and trace in royal blue) reflects broad application in hematology and blood banking.
• Citrate maintains a 9:1 blood-to-anticoagulant ratio; good practice requires careful filling and inversion to preserve the sample integrity for coagulation studies.

Page 72–76 — Heparin, PST, and Coagulation Tubes

• Heparin forms: ammonium, lithium, and sodium; the most common uses are lithium and sodium heparin.
• Heparin tubes (green tops, mint/apple/tree green; blue stripe microhematocrit tubes) are used in chemistry panels and other settings; PST tubes may include gel separators.
• Some heparin tubes also contain gel separators to create plasma/serum barriers after centrifugation (PST).

Page 77–79 — Oxalates, SPS, and Fluoride Tubes

• Potassium oxalate used with fluoride in gray tubes for glucose testing; involves 8–10 inversions.
• SPS is the anticoagulant used for blood cultures; banana-yellow tops; immediate inversion (8–10x).
• Sodium fluoride (antiglycolytic) is the additive for preserving glucose; gray tubes require rapid inversion (5–10x).

Page 80–82 — Clot Activators and Serum Separator Tubes (SST)

• Clot activators accelerate clotting for serum collection; clotting surface can be silica particles or thrombin.
• SST tubes contain a thixotropic gel separator that moves between cells and serum during centrifugation, forming a barrier to reduce cell–serum contact and preserve analytes.
• SST use: chemistry and serology testing; after centrifugation, the gel barrier remains to improve sample stability.

Page 83–84 — Trace Element-Free Tubes

• Trace Element-Free tubes are manufactured from materials free of trace elements to prevent contamination in trace element testing, toxicology, and nutrient determinations.
• These tubes are inverted 5–10x to mix the additive properly and avoid leaching from tube materials.

Page 85 — Activity: Know Your Blood Collection Tubes

• Activity instruction: Create a chart for the vacutainer tubes discussed, including:
  • Colour of the stopper
  • Anticoagulant
  • How clotting is inhibited
  • How many times to invert
  • Special notes
• Purpose: reinforce tube identification and correct handling for accurate testing.

Page 86–88 — Order of Draw Details (Venipuncture and Syringe Collections)

• Explicit orders of draw sequences to minimize carryover by additives:
  • For venipuncture and syringe collections, follow the sequence to reduce cross-contamination.
• EDTA has the strongest potential to affect subsequent tubes; this drives the priority in the order of draw.
• Typical sequence (venipuncture/syringe):
  • 1) Blood cultures + SPS
  • 2) Sodium Citrate (light blue)
  • 3) Serum Tube (Red/Gold) with/without clot activator/gel
  • 4) Heparin (green) tubes
  • 5) EDTA (purple/pink)
  • 6) Sodium Fluoride/Potassium Oxalate (gray)
• For capillary collection, order of draw follows different rules from venipuncture to minimize carryover.

Page 89–91 — Capillary Order of Draw

• Capillary collection requires a distinct order of draw to avoid bias and ensure proper results.
• Key note: Capillary tests (e.g., certain glucose tests, some blood gases) must be collected quickly to minimize platelet clumping and clot formation.
• The slide shows a numeric ordering sequence for capillary collections; the exact numbers vary by protocol, but the principle is to avoid contamination of additive carryover between tubes.

Page 92–93 — Carry Over / Cross-Contamination

• Carry over or cross-contamination occurs when additives transfer from one tube to the next.
• Causes include:
  • Transferring blood from a syringe into an evacuated tube when not in the correct order
  • Incorrect draw order leading to EDTA contamination of other tubes
• EDTA carryover can cause elevated potassium and low calcium (and potentially altered ALP) in subsequent samples; any sample with carryover must be recollected.

Page 94–96 — Tissue Thromboplastin Contamination and Microbial Contamination

• Tissue thromboplastin contamination occurs when tissue factor enters a sample (e.g., via needle during venipuncture) and activates coagulation, potentially affecting coagulation testing.
• Tissue thromboplastin contamination can be picked up by the needle and carried into the sample, affecting clotting tests.
• For coagulation tests, a discard tube (a none additive red tube) should be drawn first to remove carryover prior to the actual test sample.
• Microbial contamination is a concern for blood cultures; proper site cleaning and sterile technique are essential; blood culture bottles must be collected first in the order of draw and are highly susceptible to anticoagulant contamination; contamination can cause false positives and delay patient care.

Page 97 — Questions?

• Final prompt for questions to clarify any topics covered in the session.

Overall, this deck presents a comprehensive, page-by-page walkthrough of venipuncture, with a strong emphasis on pre-analytical quality and error prevention. The key themes include the critical importance of patient identification, site selection, tourniquet use, proper venipuncture technique, handling and labeling of specimens, and the strict adherence to the order of draw to prevent carryover of additives. It also details the wide range of collection tubes, anticoagulants, and their appropriate testing applications, along with practical station setups and workflow considerations to minimize errors across pre-analytical, analytical, and post-analytical phases.

Key formulas / constants observed:

• Fill ratio for citrate tubes: $9:1$ (blood:anticoagulant) when drawing sodium citrate tubes.
• Inversion counts vary by additive; typical guidance calls for multiple gentle inversions as per manufacturer instructions (e.g., $8\text{-}10\text{x}$ for certain additives like SPS or fluoride tubes).
• Tourniquet time: up to $1\text{ minute}$ on, with switching or removal to prevent hemoconcentration.
• Pre-analytical error share: approximately $90\%$ of total errors occur in the pre-analytical phase.

Note: Throughout the notes, remember to align with your local lab’s SOPs and the specific manufacturer instructions for each tube and additive, as variations exist between brands and institutions.